Skip to content
Gayatri BioOrganics logo

Gayatri BioOrganics

524564 BSE
₹8.15

Close ·

P/E
Not meaningful: loss-making over the last twelve months
View as Markdown
MCP
Close 4 Nov 2026 ₹8.15 −3.58 −30.5% 1Y
Start ₹11.73

Key Fundamentals

MicrocapChemicals & PetrochemicalsChemicals

Price-based figures at the close · EPS basis: Standalone · TTM

ROCE
−152.00%
Debt to Equity
Not meaningful: shareholders’ equity is negative
EPS (TTM)
−₹0.12
Book Value
−₹4.70
Market Cap
—
P/E (TTM)
Not meaningful: loss-making over the last twelve months
P/B
Not meaningful: book value is negative
ROE
Not meaningful: shareholders’ equity is negative
Dividend Yield
0.00%
EBITDA
−₹80.00 L
52W High
₹20.25
52W Low
₹6.25

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

33 Poor

Data confidence 73/100

Category scores

Quality
25
Poor
Returns, margins, earnings quality 24% weight
Valuation
52
Average
Cheap vs sector & own history 26% weight
Financial Health
7
Poor
Solvency, leverage, coverage 10% weight
Momentum
11
Poor
Trend strength, vol-adjusted 13% weight
Ownership
48
Average
FII/DII/promoter flows 26% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

No strengths listed

Weaknesses

4
  • Company has low interest coverage ratio.
  • Promoter holding is low: 21.6%
  • Contingent liabilities of Rs.22.6 Cr.
  • Promoter holding has decreased over last 3 years: -19.0%

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallBullish568
OscillatorsBearish261
Moving AveragesStrong Bullish307

Key readings

RSI (14)
59.59
Neutral
MACD (12,26,9)
0.09
Bearish
SMA (50)
7.75
Bullish
SMA (200)
10.96
Bearish

As of

Growth Rate

From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.

Revenue

Revenue growth by window
10Y−100.00%
5YZero base
3Y−100.00%
1YZero base
TTMZero base

Net profit

Net profit growth by window
10YLoss narrowed by ₹37.62 Cr
5YLoss widened by ₹0.61 Cr
3YLoss widened by ₹0.10 Cr
1YLoss widened by ₹0.38 Cr
TTMLoss widened by ₹0.18 Cr

Operating cash flow

Operating cash flow growth by window
10YOutflow narrowed by ₹26.40 Cr
5YOutflow narrowed by ₹0.44 Cr
3YOutflow narrowed by ₹0.48 Cr
1YOutflow narrowed by ₹0.47 Cr
TTM—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
10YNo sales
5YNo sales
3YNo sales
1YNo sales
TTMNo sales

Revenue by year

Revenue by year, ₹ crore
Mar 2017₹79.32 Cr
Mar 2018₹173 Cr
Mar 2019₹155 Cr
Mar 2020₹0.00 Cr
Mar 2021₹0.00 Cr
Mar 2022₹0.00 Cr
Mar 2023₹1.67 Cr
Mar 2024₹0.00 Cr
Mar 2025₹0.00 Cr
Mar 2026₹0.00 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2017−₹82.65 Cr
Mar 2018−₹19.14 Cr
Mar 2019−₹15.51 Cr
Mar 2020₹84.47 Cr
Mar 2021−₹0.50 Cr
Mar 2022−₹0.50 Cr
Mar 2023−₹1.01 Cr
Mar 2024−₹0.68 Cr
Mar 2025−₹0.73 Cr
Mar 2026−₹1.11 Cr

Quarterly Results

₹ Cr
524564 quarterly results, ₹ crore
Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
0
0
0
0
0
0
0
0
0
0
0
0
2.34
Expenses
0.18
0.07
0.1
0.18
0.15
0.11
0.08
0.1
0.18
0.12
0.13
0.32
2.33
Operating Profit
−0.18
−0.07
−0.1
−0.18
−0.15
−0.11
−0.08
−0.1
−0.18
−0.12
−0.13
−0.32
0.01
OPM %
—
—
—
—
—
—
—
—
—
—
—
—
0.43%
Other Income
0
0
0
0
0
0
0
0
0
0
0
0
0
Interest
0.02
0.04
0.04
0.05
0.06
0.07
0.08
0.07
0.08
0.09
0.09
0.1
0.11
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
0
PBT
−0.2
−0.11
−0.14
−0.23
−0.21
−0.18
−0.16
−0.17
−0.26
−0.21
−0.22
−0.42
−0.1
Tax %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Net Profit
−0.2
−0.11
−0.14
−0.23
−0.21
−0.18
−0.16
−0.17
−0.26
−0.21
−0.22
−0.42
−0.1
EPS (₹)
−0.03
−0.01
−0.02
−0.03
−0.03
−0.02
−0.02
−0.02
−0.03
−0.03
−0.03
−0.05
−0.01

Profit & Loss

₹ Cr
524564 profit and loss, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
256
137
79.32
173
155
0
0
0
1.67
0
0
0
2.34
Expenses
241
162
129
197
159
0.61
0.5
0.5
2.44
0.53
0.45
0.75
2.9
Operating Profit
15.31
−24.81
−49.21
−23.86
−3.61
−0.61
−0.5
−0.5
−0.77
−0.53
−0.45
−0.75
−0.56
OPM %
5.98%
−18.08%
−62.04%
−13.77%
−2.32%
—
—
—
−46.11%
—
—
—
−23.93%
Other Income
1.27
0.96
−16.53
11.87
2.1
85.09
0
0
0
0
0
0
0
Interest
9.39
12.74
11.57
0.19
4.71
0.01
0
0
0.03
0.15
0.28
0.36
0.39
Depreciation
2.37
2.13
5.34
6.96
9.29
0
0
0
0
0
0
0
0
PBT
4.82
−38.72
−82.65
−19.14
−15.51
84.47
−0.5
−0.5
−0.8
−0.68
−0.73
−1.11
−0.95
Tax %
18.26%
0%
0%
0%
0%
0%
0%
0%
26.25%
0%
0%
0%
—
Net Profit
3.93
−38.73
−82.65
−19.14
−15.51
84.47
−0.5
−0.5
−1.01
−0.68
−0.73
−1.11
−0.95
EPS (₹)
0.77
−6.27
−10.49
−2.43
−1.97
10.72
−0.06
−0.06
−0.13
−0.09
−0.09
−0.14
−0.12
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—

Balance Sheet

₹ Cr
524564 balance sheet, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
50.92
61.78
78.79
78.79
78.79
78.79
78.79
78.79
78.79
78.79
78.79
78.79
Reserves
−40.86
−79.58
−160
−181
−196
−111
−112
−112
−113
−114
−115
−116
Borrowings
88.12
116
35.11
35.11
35.11
35.11
35.11
35.11
35.66
36.36
36.9
36.98
Other Liabilities
43.94
44
151
213
227
0.46
0.47
0.6
0.44
0.37
0.66
1.74
Total Liabilities
142
142
105
145
145
3.09
2.6
2.24
1.62
1.57
1.67
1.72
Fixed Assets
47.19
45.69
0
0
0
0
0
0
0
0
0
0
CWIP
5.8
6.01
0
0
0
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
89.13
90
105
145
145
3.09
2.6
2.24
1.62
1.57
1.67
1.72
Total Assets
142
142
105
145
145
3.09
2.6
2.24
1.62
1.57
1.67
1.72

Cash Flow

₹ Cr
524564 cash flow, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
1.07
−26.48
−13.76
−2.62
−0.59
84.59
−0.52
−0.4
−0.56
−0.69
−0.55
−0.08
Investing
−7.1
−1.42
−0.75
2.62
0.82
−83.86
0
0
0
0
0
0
Financing
4.48
28.02
15.53
0
0
−0.01
0
0
0.56
0.7
0.54
0.74
Net Cash Flow
−1.55
0.12
1.02
0
0.23
0.73
−0.52
−0.4
−0.01
0.01
−0.01
0.66
Free Cash Flow
−5.04
−28.17
−16.06
−2.62
−0.59
84.59
−0.52
−0.4
−0.56
−0.69
−0.55
−0.08
CFO/OP
7
107
28
11
16
−13,867
104
80
73
130
122
11

Ratios

524564 financial ratios, annual
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
63.12
116
6.95
3.18
1.22
—
—
—
54.64
—
—
—
Inventory Days
62.87
98.3
0
0
0
—
—
—
0
—
—
—
Days Payable
58.8
79.17
—
—
—
—
—
—
—
—
—
—
Cash Conversion Cycle
67.19
135
6.95
3.18
1.22
—
—
—
54.64
—
—
—
Working Capital Days
5.32
−103
−366
−212
−271
—
—
—
−7,049
—
—
—
ROCE %
14.68%
−27.28%
−209.87%
—
—
—
−21.01%
−26.53%
−54.61%
−44.54%
−40.72%
−151.52%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Gayatri BioOrganics insights

60 extracted metrics across FY11–FY27.

Shareholding Pattern

As of Sep 2026

  • Public 53.44%
  • Others 24.89%
  • Promoters 21.59%
  • DIIs 0.08%
  • FIIs 0.01%

No promoter shares pledged as of 14 Oct 2026

Change vs previous quarter

Not shown for some quarters: Others. Not available separately for this quarter: the shareholding filing gives Public and Others as one figure, shown under Public, so Others is left blank rather than estimated.

Documents

Frequently Asked Questions about Gayatri BioOrganics

What does Gayatri BioOrganics Ltd do?
Incorporated in 1993, Gayatri Bio-Organics Ltd manufactures Starch, its derivatives and related by-products, and development of customized application for value added starch derivatives.
Where is Gayatri BioOrganics Ltd (GAYATRIBI) listed?
Gayatri BioOrganics Ltd trades under code 524564 on the BSE.
Which sector does Gayatri BioOrganics Ltd belong to?
Gayatri BioOrganics Ltd is classified under the Chemicals sector, in the Commodity Chemicals industry.
What is the 52-week high and low of Gayatri BioOrganics Ltd?
Over the last 52 weeks Gayatri BioOrganics Ltd has traded between ₹6.25 and ₹20.25 as of 4 Nov 2026.

Company Information

Incorporated in 1993, Gayatri Bio-Organics Ltd manufactures Starch, its derivatives and related by-products, and development of customized application for value added starch derivatives.

Website gayatribioorganics.com
Face Value ₹10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/524564.md for Gayatri BioOrganics Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Chemical & Petrochemical stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month